[go: up one dir, main page]

ES557048A0 - Procedimiento para preparar peptidos triofluormetilcetona-sustituidos - Google Patents

Procedimiento para preparar peptidos triofluormetilcetona-sustituidos

Info

Publication number
ES557048A0
ES557048A0 ES557048A ES557048A ES557048A0 ES 557048 A0 ES557048 A0 ES 557048A0 ES 557048 A ES557048 A ES 557048A ES 557048 A ES557048 A ES 557048A ES 557048 A0 ES557048 A0 ES 557048A0
Authority
ES
Spain
Prior art keywords
triofluormetilcetone
preparing
procedure
substituted peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557048A
Other languages
English (en)
Other versions
ES8707551A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858501524A external-priority patent/GB8501524D0/en
Priority claimed from GB858501523A external-priority patent/GB8501523D0/en
Priority claimed from GB858501522A external-priority patent/GB8501522D0/en
Application filed by ICI Americas Inc filed Critical ICI Americas Inc
Publication of ES557048A0 publication Critical patent/ES557048A0/es
Publication of ES8707551A1 publication Critical patent/ES8707551A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/02—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/43—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557048A 1985-01-22 1986-09-01 Procedimiento para preparar peptidos triofluormetilcetona-sustituidos Expired ES8707551A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858501524A GB8501524D0 (en) 1985-01-22 1985-01-22 Tetrapeptide derivatives
GB858501523A GB8501523D0 (en) 1985-01-22 1985-01-22 Tripeptide derivatives
GB858501522A GB8501522D0 (en) 1985-01-22 1985-01-22 Dipeptide derivatives

Publications (2)

Publication Number Publication Date
ES557048A0 true ES557048A0 (es) 1987-08-01
ES8707551A1 ES8707551A1 (es) 1987-08-01

Family

ID=27262565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES551113A Expired ES8706169A1 (es) 1985-01-22 1986-01-22 Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
ES557048A Expired ES8707551A1 (es) 1985-01-22 1986-09-01 Procedimiento para preparar peptidos triofluormetilcetona-sustituidos
ES557363A Expired ES8802526A1 (es) 1985-01-22 1987-01-30 Procedimiento para preparar peptidos trifluormetilcetona-sustituidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551113A Expired ES8706169A1 (es) 1985-01-22 1986-01-22 Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557363A Expired ES8802526A1 (es) 1985-01-22 1987-01-30 Procedimiento para preparar peptidos trifluormetilcetona-sustituidos

Country Status (25)

Country Link
US (2) US4910190A (es)
EP (1) EP0189305B1 (es)
JP (2) JPH0759591B2 (es)
KR (1) KR910002689B1 (es)
CN (1) CN1027640C (es)
AU (1) AU594658B2 (es)
CA (1) CA1341023C (es)
CZ (1) CZ278063B6 (es)
DE (1) DE3686172T2 (es)
DK (1) DK172736B1 (es)
ES (3) ES8706169A1 (es)
FI (1) FI84171C (es)
GB (1) GB8600263D0 (es)
GR (1) GR860169B (es)
HK (1) HK18097A (es)
HU (1) HU206370B (es)
IE (1) IE58957B1 (es)
IL (1) IL77680A (es)
NO (1) NO169493C (es)
PH (1) PH26575A (es)
PL (1) PL150268B1 (es)
PT (1) PT81887B (es)
SK (1) SK278095B6 (es)
UA (1) UA39093C2 (es)
ZW (1) ZW1486A1 (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
US5296608A (en) * 1988-04-25 1994-03-22 Hoffman-La Roche Inc. Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides
US5182263A (en) * 1988-04-25 1993-01-26 Hoffmann-La Roche Inc. Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
GB8910550D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
ATE178336T1 (de) * 1990-05-24 1999-04-15 Zeneca Ltd Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DK0458536T3 (da) * 1990-05-24 1998-10-19 Zeneca Ltd Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
GB9014132D0 (en) * 1990-06-25 1990-08-15 Ici Plc Agent for therapy
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
JP3442075B2 (ja) * 1991-05-23 2003-09-02 メレルファーマス−テイカルズ インコーポレイテッド 結合組織分解を防止するためのカテプシンｇとエラスターゼの阻害剤
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
WO1993003011A1 (fr) * 1991-08-08 1993-02-18 Yamanouchi Pharmaceutical Co., Ltd. Derive d'uree
GB9216272D0 (en) * 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
AU658426B2 (en) * 1991-08-15 1995-04-13 Zeneca Limited Substituted heterocycles
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
WO1993021214A1 (en) * 1992-04-16 1993-10-28 Zeneca Limited Alpha-aminoboronic acid peptides and their use as elastase inhibitors
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9214053D0 (en) * 1992-07-02 1992-08-12 Ici Plc Heterocyclic amides
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6693072B2 (en) * 1994-06-02 2004-02-17 Aventis Pharmaceuticals Inc. Elastase inhibitors
ATE246708T1 (de) * 1994-06-02 2003-08-15 Aventis Pharma Inc Elatase-inhibitoren
AU690986B2 (en) * 1994-06-02 1998-05-07 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
DK0762887T3 (da) * 1994-06-02 2002-01-14 Merrell Pharma Inc Acylerede enolderivater som prodrugs for elastase-hæmmere
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6559127B1 (en) * 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) * 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6682554B2 (en) * 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
GB9928882D0 (en) * 1999-12-08 2000-02-02 Zeneca Ltd Assay method
US6403612B2 (en) * 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
US20040006093A1 (en) * 2000-10-17 2004-01-08 Thorsett Eugene D. Compounds which inhibit leukocyte adhesion mediated by VLA-4
EP2290098A1 (en) 2002-01-28 2011-03-02 Ambion, Inc. Preparing crude biological extracts using protease, suitable for preparing cDNA
MXPA04007552A (es) 2002-02-05 2004-11-10 Dainippon Pharmaceutical Co Compuestos heterociclicos que tienen actividad inhibidora de elastasa e intermediarios de los mismos.
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
EP2955233A1 (en) 2008-12-19 2015-12-16 Life Technologies Corporation Proteinase K inhibitors, methods and compositions therefor
EP3405183A4 (en) 2016-01-18 2019-12-11 Arisan Therapeutics Inc. ADAMATE DERIVATIVES FOR TREATING A FILOVIRUS INFECTION
US10710957B2 (en) 2017-01-09 2020-07-14 University Of Central Florida Research Foundation, Inc. Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB195212A (en) * 1922-01-30 1923-03-29 Edward Crawshaw Improvements in expansion joints between steam boilers and their settings or flue walls
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
EP0124317B1 (en) * 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
CH672792A5 (es) * 1985-02-19 1989-12-29 Sandoz Ag
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
DE3782191T2 (de) * 1986-06-05 1993-02-25 Ici America Inc Difluorketoverbindungen.

Also Published As

Publication number Publication date
PL150268B1 (en) 1990-05-31
US4910190A (en) 1990-03-20
FI84171B (fi) 1991-07-15
ES557363A0 (es) 1988-07-01
PL257573A1 (en) 1987-03-23
JPH05246984A (ja) 1993-09-24
KR910002689B1 (ko) 1991-05-03
FI860281A0 (fi) 1986-01-21
DK172736B1 (da) 1999-06-21
CA1341023C (en) 2000-06-13
DE3686172T2 (de) 1993-01-14
US5726158A (en) 1998-03-10
HU206370B (en) 1992-10-28
DK30886D0 (da) 1986-01-21
JPH0759591B2 (ja) 1995-06-28
HK18097A (en) 1997-02-13
NO169493B (no) 1992-03-23
FI84171C (fi) 1991-10-25
CN1027640C (zh) 1995-02-15
DK30886A (da) 1986-07-23
ZW1486A1 (en) 1987-09-30
EP0189305B1 (en) 1992-07-29
GB8600263D0 (en) 1986-02-12
HUT39464A (en) 1986-09-29
PT81887A (en) 1986-02-01
EP0189305A3 (en) 1988-10-05
IE58957B1 (en) 1993-12-01
AU5262386A (en) 1986-07-31
ES8707551A1 (es) 1987-08-01
SK278095B6 (en) 1995-12-06
JPS61218518A (ja) 1986-09-29
CN86101066A (zh) 1986-11-05
NO169493C (no) 1992-07-01
UA39093C2 (uk) 2001-06-15
ES8802526A1 (es) 1988-07-01
CZ278063B6 (en) 1993-08-11
KR860005835A (ko) 1986-08-13
FI860281A7 (fi) 1986-07-23
NO860190L (no) 1986-07-23
IE860180L (en) 1986-07-22
DE3686172D1 (de) 1992-09-03
CS39586A3 (en) 1992-01-15
PH26575A (en) 1992-08-19
AU594658B2 (en) 1990-03-15
PT81887B (pt) 1988-05-27
JPH0680039B2 (ja) 1994-10-12
ES551113A0 (es) 1987-05-16
EP0189305A2 (en) 1986-07-30
ES8706169A1 (es) 1987-05-16
GR860169B (en) 1986-05-15
IL77680A (en) 1990-12-23

Similar Documents

Publication Publication Date Title
ES557363A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES553989A0 (es) Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas
ES2023841B3 (es) Procedimiento para preparar mezclas antiespumantes
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
MX161186A (es) Procedimiento para preparar peptidos
ES543973A0 (es) Procedimiento para preparar peptidos
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
MX159506A (es) Procedimiento para preparar acidos quinolincarboxilicos
ES550896A0 (es) Procedimiento para preparar espiro-dioxolanos-ditiolanos y oxotiolanos
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES557193A0 (es) Procedimiento para preparar polipeptidos.
MX160995A (es) Procedimiento para prepara peptidos
ES557691A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES555561A0 (es) Procedimiento para preparar celalosporinas
ES554112A0 (es) Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES551695A0 (es) Procedimiento para preparar proteinas eventualmente glicosiladas
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES545868A0 (es) Procedimiento para preparar peptidos
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES555384A0 (es) Procedimiento de preparar diosmina
ES557614A0 (es) Procedimiento para preparar disulfuros heterociclicos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040604